<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03930381</url>
  </required_header>
  <id_info>
    <org_study_id>2018-9083</org_study_id>
    <nct_id>NCT03930381</nct_id>
  </id_info>
  <brief_title>Adapting and Expanding the Asthma-Educator App</brief_title>
  <official_title>Adapting and Expanding the Algorithmic Software Tool to Help Manage Asthma (ASTHMAXcel) for Youth With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project seeks to test and refine an adapted/expanded version of a previously created
      ASTHMAXcel app.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will test the adapted app on participants ages 15-21 (recruited from outpatient
      primary and specialty care sites at Montefiore) with asthma, for a period of 6 weeks, and
      will conduct formative and summative evaluation of the application's functionality and
      usability. The investigators will also be collecting process and clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Study will eventually compare health outcomes between a group given the ASTHMAXcel intervention and a group given Usual Care</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Asthma Control to 2 Month Asthma Control</measure>
    <time_frame>Post-Refinement Baseline, 2 Months</time_frame>
    <description>Asthma symptom burden as measured by the Asthma Control Test
Score Scale: 5 (min = worse); 25 (max = better outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Asthma Control to 4 Month Asthma Control</measure>
    <time_frame>Post-Refinement Baseline, 4 Months</time_frame>
    <description>Asthma symptom burden as measured by the Asthma Control Test
Score Scale: 5 (min = worse); 25 (max = better outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>Post-Refinement Baseline, 2 Months, 4 Months</time_frame>
    <description>Patient satisfaction with study measured by the Client Satisfaction Questionnaire-8
Score Scale: 8 (min = worse outcome); 32 (max = better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Interface Satisfaction</measure>
    <time_frame>Baseline, Week 6, Post-Refinement Baseline</time_frame>
    <description>Patient satisfaction with ASTHMAXcel app interface measured by Questionnaire for User Interface Survey (QUIS)
Score Scale: 0 (min = worse outcome); 261 (max = better outcome)
Answers scale from 0 (terrible/hard to understand)) to 9 (wonderful/easy to understand)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Usage</measure>
    <time_frame>Week 6, 2 Month, 4 Month</time_frame>
    <description>Time spent on app and different screens of app, measured using Google Analytics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency Department Visits</measure>
    <time_frame>Post-Refinement Baseline, 2 Month, 4 Month</time_frame>
    <description>Self-Reported Emergency Department (ED) visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Quality of Life</measure>
    <time_frame>Post-Refinement Baseline, 2 Month, 4 Month</time_frame>
    <description>Quality of life of participants, measured by mini-Asthma Quality of Life Questionnaire
Score Scale: 15 (min = worse outcome); 105 (max = better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway Obstruction</measure>
    <time_frame>Post-Refinement Baseline, 2 Month, 4 Month</time_frame>
    <description>Obstruction measure from spirometry (Forced Expiratory Volume (FEV) % predicted and FEV/FVC [Forced Vital Capacity] ratio)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>Post-Refinement Baseline, 2 Month, 4 Month</time_frame>
    <description>Self-reported adherence by patient using Medication Adherence Report Scale
Score Scale: 10 (min = worse outcome); 50 (max = better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Literacy</measure>
    <time_frame>Post-Refinement Baseline</time_frame>
    <description>Ability for patients to comprehend Newest Vital Sign screening tool</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Knowledge</measure>
    <time_frame>Post-Refinement Baseline, 2 Month, 4 Month</time_frame>
    <description>Will use the Child Asthma Illness Representation Survey (AIRS) to asses patients knowledge on asthma as well as their attitudes towards their condition.
Score Scale: 4 (min = worse outcome); 20 (max = better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Symptom Perception</measure>
    <time_frame>Week 2, Week 4 , Week 6 (Pre and Post Refinement)</time_frame>
    <description>Ability of participants to perceive their asthma symptoms by using the ASTHMAXcel app and a peak flowmeter</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will download the ASTHMAXcel application and use it for the duration of the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will just receive normal provider care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ASTHMAXcel App</intervention_name>
    <description>ASTHMAXcel includes interactive games, educational videos, quizzes and personalized feedback to teach different aspects of asthma management.</description>
    <arm_group_label>Intervention Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English-speaking individuals between 15-21

          -  Persistent asthma (diagnosis made by a healthcare provider)

          -  On a daily controller medication

          -  Able to give informed consent

          -  Smartphone (iOS or Android) access

        Exclusion Criteria:

          -  Use of oral corticosteroids in the 2 weeks prior to the baseline visit

          -  Pregnancy

          -  Severe psychiatric or cognitive problems that would prohibit an individual from
             understanding and completing the protocol

          -  Patients that previously received the ASTHMA-Educator application
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunit Jariwala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sunit Jariwala, MD</last_name>
    <phone>(718) 920-4767</phone>
    <email>sjariwal@montefiore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Obumneme Njeze, BS</last_name>
    <phone>(718) 920-4767</phone>
    <email>onjeze@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunit Jariwala, MD</last_name>
      <phone>718-920-4767</phone>
      <email>sjariwal@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Obumneme Njeze, BS</last_name>
      <phone>(718) 920-4767</phone>
      <email>onjeze@montefiore.org</email>
    </contact_backup>
    <investigator>
      <last_name>Sunit Jariwala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 5, 2019</study_first_submitted>
  <study_first_submitted_qc>April 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>May 3, 2020</last_update_submitted>
  <last_update_submitted_qc>May 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Sunit P. Jariwala</investigator_full_name>
    <investigator_title>Associate Professor (Medicine)</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

